Target Price Playground
RXI
$186.51
Swing & Horizon Engine
Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on RXI? Launch with your exact active legs & +12.0% target.
โก Quant Efficiency Alert: Bull Call Spread Delivers
+199.1% ROI
vs
+137.8% ROI
on Long Call at $208.89 Target
Bull Call Spread cuts entry cost by 21% ($799 vs $1,005), lowers breakeven to $192.99 (+3.5%), and slashes daily theta burn from $8.94/d to $3.30/d.
Forward Projection
If price hits $209 by Jan 15
Multi-Option Simulator
Pre-expiry +3d/+5d & Overlays
Options Architect
Multi-leg solver & Greeks
1x1x1 Structure
Reverse Time-Diagonal + Call
๐ Strategy
Long Stock
Long Call
Long Put
Bull Call Spread
Bear Put Spread
Bear Call Credit Spread
Bull Put Credit Spread
Covered Call
Protective Put
Cash-Secured Put
Diagonal Put Spread
Long Straddle
Bullish. Unlimited upside, capped loss = premium paid.
๐ฏ Target
1-Click Institutional Target Anchors:
55d from today
โ๏ธ Legs
LONG CALL ยท $185 ยท Jan '27
Qty 1 ยท Premium $10.05 ยท ฮ 0.57
P&L at Expiry
Stock (100 sh)
Long Call
Now
Target
๐ก Stock vs Options at Target
If RXI hits $209 by Jan 15: the long call returns +$1,384 (137.8%) on $1,005 risked, vs +$2,238 (12.0%) for 100 shares on $18,651. Options give 11.5ร capital efficiency.
๐ Expiry & Gamma Wall Alignment
Options expire Jan 15, 2027 (55 days out). P&L shown is the value at expiry if RXI is at $209.
๐ Projected Return
P&L if RXI hits $209 by Jan 15
+$1,384
+137.8% on $1,005 risked
Max Profit
Unlimited
Unlimited upside
Max Loss
โ$1,005
Premium paid
Break-even
$195.05
+4.58% from spot
Prob. of Profit at Expiry (PoP)
35.0%
Above breakeven ($195.05)
ยท Touch Target: 30%
30-Day Theta Burn (If Flat)
โ$268
26.7% of entry cost ยท Daily ฮ: $-8.94/day
Net ฮ / ฮ / V
57.39 / -8.94 / 28.39
per spread, per $1 move / day / vol pt
๐ P&L Scenarios โ what happens at different prices and dates
| RXI Price | Today | +3d (Nov 24) | +7d (Nov 28) | Dec 9 | Dec 27 | Jan 15 (exp) |
|---|---|---|---|---|---|---|
| $149 (-20%) | -$977 | -$981 | -$986 | -$997 | -$1,005 | -$1,005 |
| $159 (-15%) | -$908 | -$918 | -$931 | -$964 | -$1,000 | -$1,005 |
| $168 (-10%) | -$749 | -$767 | -$791 | -$857 | -$959 | -$1,005 |
| $177 (-5%) | -$455 | -$479 | -$512 | -$610 | -$795 | -$1,005 |
| $183 (-2%) | -$201 | -$228 | -$264 | -$373 | -$588 | -$1,005 |
| $187 (0%) โ spot | +$0 | -$27 | -$64 | -$175 | -$395 | -$854 |
| $190 (+2%) | +$226 | +$199 | +$162 | +$53 | -$160 | -$481 |
| $196 (+5%) | +$610 | +$584 | +$549 | +$448 | +$261 | +$79 |
| $205 (+10%) | +$1,344 | +$1,323 | +$1,295 | +$1,215 | +$1,090 | +$1,011 |
| $209 (+12%) โ target | +$1,665 | +$1,646 | +$1,620 | +$1,550 | +$1,446 | +$1,384 |
| $214 (+15%) | +$2,168 | +$2,152 | +$2,130 | +$2,073 | +$1,994 | +$1,944 |
| $224 (+20%) | +$3,045 | +$3,032 | +$3,016 | +$2,975 | +$2,920 | +$2,876 |
Uses RXI's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.